1,2- and 1,4-Cyclohexanediol: major urinary metabolites and biomarkers of exposure to cyclohexane, cyclohexanone, and cyclohexanol in humans.
J Mráz, E Gálová, H Nohová, D Vitková
Index: Int. Arch. Occup. Environ. Health 71(8) , 560-5, (1998)
Full Text: HTML
Abstract
The metabolism and toxicokinetics of cyclohexane (CH) and cyclohexanol (CH-ol), important solvents and chemical intermediates, were studied in volunteers after 8-h periods of inhalation exposure at concentrations of 1010 and 236 mg m(-3), respectively (occupational exposure limits: CH, 1050 mg m(-3); CH-ol, 200 mg m(-3)). Of the dose of absorbed parent compounds, the yields of urinary CH-ol and 1,2- and 1,4-cyclohexanediol (CH-diol) were 0.5%, 23.4%, and 11.3%, respectively, after exposure to CH and 1.1%, 19.1%, and 8.4%, respectively, after exposure to CH-ol as determined by a gas chromatography method involving hydrolysis of glucuronide conjugates. The metabolic patterns of CH and CH-ol were very similar to that of cyclohexanone (CH-one) studied in the laboratory previously. For all three compounds, peak excretion of CH-ol occurred at the end of the exposure period, after which it decayed rapidly. Excretion curves of 1,2- and 1,4-CH-diol reached maximal values within 0-6 h postexposure, with subsequent elimination half-lives being 14-18 h. The rate-limiting step in the elimination of CH compounds from the organism is renal clearance of CH-diols. Determination of CH-diols in end-of-shift urine samples is recommended as a useful new method of biomonitoring of CH, CH-ol, and CH-one at the workplace. However, due to accumulation of CH-diols in the body during repeated exposure, quantitative relationships between the exposure and the level of CH-diols have to be adjusted according to the day of sampling during the working week.
Related Compounds
Related Articles:
1999-06-01
[Scand. J. Work. Environ. Health 25(3) , 233-7, (1999)]
2003-04-22
[Carbohydr. Res. 338(9) , 963-8, (2003)]
1999-03-01
[Int. Arch. Occup. Environ. Health 72(2) , 115-20, (1999)]
2001-06-01
[Appl. Microbiol. Biotechnol. 55(6) , 721-6, (2001)]
Insight into acid-mediated asymmetric spirocyclization in the presence of a chiral diol.
2000-10-01
[Chem. Pharm. Bull. 48(10) , 1536-40, (2000)]